MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Cadonilimab

  1. Home
  2. Drugs
  3. Cadonilimab
  4. Clinical Trials

Clinical Trials Related to Cadonilimab

Related studies linked through entity extraction aliases.

NCT07700979

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Status
NOT_YET_RECRUITING
Phase
PHASE3

NCT07631000

A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

Status
RECRUITING
Phase
PHASE2

NCT07446257

THIO and Cadonilimab in Resectable Hepatocellular Carcinoma

Status
NOT_YET_RECRUITING
Phase
EARLY_PHASE1

NCT06511726

Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT06187961

HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2

NCT05944224

A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

Status
RECRUITING
Phase
PHASE1/PHASE2

NCT05426005

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE1/PHASE2

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.